chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Oral pruritus, Pruritus, Sensitive skin
Clinical narrative: Pruritus; Like her skin is very sensitive to anything that is touching it; It worried her/has so much anxiety over this; Itchy mouth; Thrush in mouth; Her mouth gets really dry; A little bit of nausea; This is very depressing; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Pruritus), SENSITIVE SKIN (Like her skin is very sensitive to anything that is touching it), ANXIETY (It worried her/has so much anxiety over this), ORAL PRURITUS (Itchy mouth) and ORAL CANDIDIASIS (Thrush in mouth) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hormone replacement therapy. Concomitant products included ESTROGENS CONJUGATED, MEDROXYPROGESTERONE ACETATE (PREMPRO), FAMOTIDINE (PEPCID [FAMOTIDINE]) and LORAZEPAM for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PRURITUS (Pruritus), SENSITIVE SKIN (Like her skin is very sensitive to anything that is touching it), ANXIETY (It worried her/has so much anxiety over this), ORAL PRURITUS (Itchy mouth), ORAL CANDIDIASIS (Thrush in mouth), DRY MOUTH (Her mouth gets really dry), NAUSEA (A little bit of nausea) and DEPRESSION (This is very depressing). The patient was treated with SALICYLIC ACID (EUCERIN [SALICYLIC ACID]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Pruritus), SENSITIVE SKIN (Like her skin is very sensitive to anything that is touching it), ANXIETY (It worried her/has so much anxiety over this), ORAL PRURITUS (Itchy mouth), ORAL CANDIDIASIS (Thrush in mouth), DRY MOUTH (Her mouth gets really dry), NAUSEA (A little bit of nausea) and DEPRESSION (This is very depressing) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported itching were in odd spots, behind her knee, back of neck, hands, bend of her hands, in really weird places and felt very horrible. Patient used an unspecified anti-itch cream for the treatment of the events.   According to the latest follow-up conditions still persisted but she felt slightly better.   Most recent FOLLOW-UP information incorporated above includes: On 24-Mar-2021: Reporter information, medical history, event Information and treatment medicine updated. On 06-Apr-2021: Update on outcome of events. On 09-Apr-2021: Events outcome updated.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Bruising; Warmth; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Bruising), VACCINATION SITE WARMTH (Warmth) and VACCINATION SITE SWELLING (Swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE BRUISING (Bruising), VACCINATION SITE WARMTH (Warmth) and VACCINATION SITE SWELLING (Swelling). At the time of the report, VACCINATION SITE BRUISING (Bruising), VACCINATION SITE WARMTH (Warmth) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided by the reporter.   Patient reported that she had delayed site reaction one week after injection. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The concomitant medications were not provided The treatment information was not  provided
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chest pain, Gastrooesophageal reflux disease, Vaccination site pain
Clinical narrative: reflux; chest pain; stomach is upset; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (reflux), VACCINATION SITE PAIN (sore arm), CHEST PAIN (chest pain) and ABDOMINAL DISCOMFORT (stomach is upset) in a 68-year-old female patient who received mRNA-1273 (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included Reflux gastritis. Concomitant products included MAGNESIUM OXIDE HEAVY, SODIUM BICARBONATE (ANTACID C).   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form.   On 10-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm).   On an unknown date, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (reflux), CHEST PAIN (chest pain) and ABDOMINAL DISCOMFORT (stomach is upset). At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (reflux), VACCINATION SITE PAIN (sore arm), CHEST PAIN (chest pain) and ABDOMINAL DISCOMFORT (stomach is upset) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Intramuscular) was unknown.  Most recent FOLLOW-UP information incorporated above includes: On 18-Mar-2021: Significant Follow up appended
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose fluctuation, Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Injection site knot (hardness); Injection site itchy; Injection site red; injection site sore; Injection site hot; Injection site raised; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE REACTION (Injection site raised), VACCINATION SITE INDURATION (Injection site knot (hardness)), VACCINATION SITE PRURITUS (Injection site itchy) and VACCINATION SITE ERYTHEMA (Injection site red) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type 2 diabetes mellitus.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE REACTION (Injection site raised), VACCINATION SITE ERYTHEMA (Injection site red) and VACCINATION SITE PAIN (injection site sore). On 18-Mar-2021, the patient experienced VACCINATION SITE INDURATION (Injection site knot (hardness)) and VACCINATION SITE PRURITUS (Injection site itchy). On 11-Mar-2021, VACCINATION SITE WARMTH (Injection site hot) outcome was unknown, VACCINATION SITE REACTION (Injection site raised) and VACCINATION SITE PAIN (injection site sore) had resolved. At the time of the report, VACCINATION SITE INDURATION (Injection site knot (hardness)), VACCINATION SITE PRURITUS (Injection site itchy) and VACCINATION SITE ERYTHEMA (Injection site red) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose fluctuation: unknown (High) Elevated blood sugar.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction, Vaccination site warmth
Clinical narrative: Injection site knot (hardness); Injection site itchy; Injection site red; injection site sore; Injection site hot; Injection site raised; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE REACTION (Injection site raised), VACCINATION SITE INDURATION (Injection site knot (hardness)), VACCINATION SITE PRURITUS (Injection site itchy) and VACCINATION SITE ERYTHEMA (Injection site red) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type 2 diabetes mellitus.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE REACTION (Injection site raised), VACCINATION SITE ERYTHEMA (Injection site red) and VACCINATION SITE PAIN (injection site sore). On 18-Mar-2021, the patient experienced VACCINATION SITE INDURATION (Injection site knot (hardness)) and VACCINATION SITE PRURITUS (Injection site itchy). On 11-Mar-2021, VACCINATION SITE WARMTH (Injection site hot) outcome was unknown, VACCINATION SITE REACTION (Injection site raised) and VACCINATION SITE PAIN (injection site sore) had resolved. At the time of the report, VACCINATION SITE INDURATION (Injection site knot (hardness)), VACCINATION SITE PRURITUS (Injection site itchy) and VACCINATION SITE ERYTHEMA (Injection site red) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose fluctuation: unknown (High) Elevated blood sugar.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort, Vaccination site induration, Vaccination site inflammation
Clinical narrative: Inflammation in arm at the injection site; Hardness in arm at the injection site; arm at the injection site does not feel good; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (Inflammation in arm at the injection site), VACCINATION SITE INDURATION (Hardness in arm at the injection site) and VACCINATION SITE DISCOMFORT (arm at the injection site does not feel good) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included Autoimmune disorder (Polymyalgia Rheumatica).    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE INFLAMMATION (Inflammation in arm at the injection site), VACCINATION SITE INDURATION (Hardness in arm at the injection site) and VACCINATION SITE DISCOMFORT (arm at the injection site does not feel good). At the time of the report, VACCINATION SITE INFLAMMATION (Inflammation in arm at the injection site), VACCINATION SITE INDURATION (Hardness in arm at the injection site) and VACCINATION SITE DISCOMFORT (arm at the injection site does not feel good) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was not reported. No treatment medication was not reported
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Myalgia
Clinical narrative: Chills; mild fatigue; body aches; joint aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (mild fatigue), MYALGIA (body aches) and ARTHRALGIA (joint aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced CHILLS (Chills), FATIGUE (mild fatigue), MYALGIA (body aches) and ARTHRALGIA (joint aches). At the time of the report, CHILLS (Chills), FATIGUE (mild fatigue), MYALGIA (body aches) and ARTHRALGIA (joint aches) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.  Company Comment - Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: rash; shingles on her left leg; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles on her left leg) and RASH (rash) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D14M20A) for COVID-19 vaccination.     No medical reported history provided by the reporter.   Concomitant products included LIDOCAINE for Pain, NAPROXEN for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced HERPES ZOSTER (shingles on her left leg). On an unknown date, the patient experienced RASH (rash). At the time of the report, HERPES ZOSTER (shingles on her left leg) and RASH (rash) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was given Antiviral (doctor gave her for the shingles).  Patient had shingles before. And before the reaction she was taking lexeril first and then tramadol, stopped taking it after the reaction.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site haemorrhage
Clinical narrative: a dot of blood seen through bandage at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (a dot of blood seen through bandage at injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included Tremor.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (a dot of blood seen through bandage at injection site). At the time of the report, VACCINATION SITE HAEMORRHAGE (a dot of blood seen through bandage at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drugs were not provided. Treatment drugs were not provided.   Reporter did not allow further contact
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Illness, SARS-CoV-2 test
Clinical narrative: Developed illness; Tested positive for COVID19 Virus; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Developed illness) and COVID-19 (Tested positive for COVID19 Virus) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypertension.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced ILLNESS (Developed illness) and COVID-19 (Tested positive for COVID19 Virus). On 30-Jan-2021, COVID-19 (Tested positive for COVID19 Virus) had resolved. At the time of the report, ILLNESS (Developed illness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Jan-2021, SARS-CoV-2 test: positive (Positive) Tested positive for COVID-19 and recovered on 30 JAN 2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included Diabetic medications and High Blood Pressure medication.  No treatment information was provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Feeling abnormal, Heart rate, Heart rate increased
Clinical narrative: shortness of breath/difficulty breathing; dizziness; rapid heartbeat; as if someone was sawing my arm off; pain in her injection arm all the way down to her fingers; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath/difficulty breathing), DIZZINESS (dizziness), VACCINATION SITE PAIN (pain in her injection arm all the way down to her fingers), HEART RATE INCREASED (rapid heartbeat) and FEELING ABNORMAL (as if someone was sawing my arm off) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M049(?)) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced DYSPNOEA (shortness of breath/difficulty breathing), DIZZINESS (dizziness), VACCINATION SITE PAIN (pain in her injection arm all the way down to her fingers), HEART RATE INCREASED (rapid heartbeat) and FEELING ABNORMAL (as if someone was sawing my arm off). At the time of the report, DYSPNOEA (shortness of breath/difficulty breathing), DIZZINESS (dizziness), VACCINATION SITE PAIN (pain in her injection arm all the way down to her fingers), HEART RATE INCREASED (rapid heartbeat) and FEELING ABNORMAL (as if someone was sawing my arm off) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: increased (High) 120.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided no treatment information provided
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: shortness of breath/difficulty breathing; dizziness; rapid heartbeat; as if someone was sawing my arm off; pain in her injection arm all the way down to her fingers; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath/difficulty breathing), DIZZINESS (dizziness), VACCINATION SITE PAIN (pain in her injection arm all the way down to her fingers), HEART RATE INCREASED (rapid heartbeat) and FEELING ABNORMAL (as if someone was sawing my arm off) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M049(?)) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced DYSPNOEA (shortness of breath/difficulty breathing), DIZZINESS (dizziness), VACCINATION SITE PAIN (pain in her injection arm all the way down to her fingers), HEART RATE INCREASED (rapid heartbeat) and FEELING ABNORMAL (as if someone was sawing my arm off). At the time of the report, DYSPNOEA (shortness of breath/difficulty breathing), DIZZINESS (dizziness), VACCINATION SITE PAIN (pain in her injection arm all the way down to her fingers), HEART RATE INCREASED (rapid heartbeat) and FEELING ABNORMAL (as if someone was sawing my arm off) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: increased (High) 120.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided no treatment information provided
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Warm around shot site after 2nd dose; Red area around shot site after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm around shot site after 2nd dose) and VACCINATION SITE ERYTHEMA (Red area around shot site after 2nd dose) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warm around shot site after 2nd dose) and VACCINATION SITE ERYTHEMA (Red area around shot site after 2nd dose). At the time of the report, VACCINATION SITE WARMTH (Warm around shot site after 2nd dose) and VACCINATION SITE ERYTHEMA (Red area around shot site after 2nd dose) outcome was unknown.            Other relevant medication history included thyroid medication. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness, Pruritus, Vaccination site pain
Clinical narrative: Itchy; Right arm feel slightly weaker; Soreness in the arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), MUSCULAR WEAKNESS (Right arm feel slightly weaker) and VACCINATION SITE PAIN (Soreness in the arm of injection) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ERGOCALCIFEROL, RETINOL PALMITATE (MULTIVITAMINS [VITAMINS NOS]) for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PRURITUS (Itchy), MUSCULAR WEAKNESS (Right arm feel slightly weaker) and VACCINATION SITE PAIN (Soreness in the arm of injection). At the time of the report, PRURITUS (Itchy), MUSCULAR WEAKNESS (Right arm feel slightly weaker) and VACCINATION SITE PAIN (Soreness in the arm of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Fatigue, Pyrexia
Clinical narrative: blister on her cheek; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (blister on her cheek), PYREXIA (fever) and FATIGUE (fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (fever) and FATIGUE (fatigue). On 10-Mar-2021, the patient experienced BLISTER (blister on her cheek). At the time of the report, BLISTER (blister on her cheek), PYREXIA (fever) and FATIGUE (fatigue) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product was reported.   No treatment information was reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Hives; Rash on back, sides, butt, stomach.; Itchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (Rash on back, sides, butt, stomach.), PRURITUS (Itchy) and URTICARIA (Hives) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 07-Mar-2021, the patient experienced RASH (Rash on back, sides, butt, stomach.) and PRURITUS (Itchy). On an unknown date, the patient experienced URTICARIA (Hives). The patient was treated with PREDNISONE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH (Rash on back, sides, butt, stomach.), PRURITUS (Itchy) and URTICARIA (Hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Blood immunoglobulin G, Body temperature, COVID-19, Cough
Clinical narrative: sore; Being achy in joints; being achy in joints and some muscles; fever spike to 103.4F; headache; No appetite; mild coughing; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), COUGH (mild coughing), PAIN IN EXTREMITY (Sore arm), PAIN (sore) and ARTHRALGIA (Being achy in joints) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported by reporter.  Concurrent medical conditions included Hypothyroidism since 23-Jan-2015. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) from 23-Jan-2015 to an unknown date for Hypothyroidism, VITAMIN C [ASCORBIC ACID], VITAMIN D NOS and ZINC for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 16-Mar-2021, the patient experienced DECREASED APPETITE (No appetite), COUGH (mild coughing), PAIN (sore), ARTHRALGIA (Being achy in joints), MYALGIA (being achy in joints and some muscles), PYREXIA (fever spike to 103.4F) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) on 16-Mar-2021 at a dose of 2 dosage form in total. On 05-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, DECREASED APPETITE (No appetite), COUGH (mild coughing), PAIN (sore), ARTHRALGIA (Being achy in joints), MYALGIA (being achy in joints and some muscles), PYREXIA (fever spike to 103.4F) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Blood immunoglobulin G: unknown (Positive) IgG positive. On 16-Mar-2021, Body temperature: 103.4 (High) 103.4 F. On 16-Mar-2021, COVID-19: unknown (Negative) COVID-19 negative. On 16-Mar-2021, Influenza virus test: unknown (Negative) Flu test negative. On 16-Mar-2021, Polymerase chain reaction: unknown (Negative) PCR negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26MAY2021, included patient demographic details, lab data  and medical history details.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Headache, Influenza virus test, Myalgia, Pain
Clinical narrative: sore; Being achy in joints; being achy in joints and some muscles; fever spike to 103.4F; headache; No appetite; mild coughing; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), COUGH (mild coughing), PAIN IN EXTREMITY (Sore arm), PAIN (sore) and ARTHRALGIA (Being achy in joints) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported by reporter.  Concurrent medical conditions included Hypothyroidism since 23-Jan-2015. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) from 23-Jan-2015 to an unknown date for Hypothyroidism, VITAMIN C [ASCORBIC ACID], VITAMIN D NOS and ZINC for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 16-Mar-2021, the patient experienced DECREASED APPETITE (No appetite), COUGH (mild coughing), PAIN (sore), ARTHRALGIA (Being achy in joints), MYALGIA (being achy in joints and some muscles), PYREXIA (fever spike to 103.4F) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) on 16-Mar-2021 at a dose of 2 dosage form in total. On 05-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, DECREASED APPETITE (No appetite), COUGH (mild coughing), PAIN (sore), ARTHRALGIA (Being achy in joints), MYALGIA (being achy in joints and some muscles), PYREXIA (fever spike to 103.4F) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Blood immunoglobulin G: unknown (Positive) IgG positive. On 16-Mar-2021, Body temperature: 103.4 (High) 103.4 F. On 16-Mar-2021, COVID-19: unknown (Negative) COVID-19 negative. On 16-Mar-2021, Influenza virus test: unknown (Negative) Flu test negative. On 16-Mar-2021, Polymerase chain reaction: unknown (Negative) PCR negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26MAY2021, included patient demographic details, lab data  and medical history details.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Polymerase chain reaction, Pyrexia
Clinical narrative: sore; Being achy in joints; being achy in joints and some muscles; fever spike to 103.4F; headache; No appetite; mild coughing; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), COUGH (mild coughing), PAIN IN EXTREMITY (Sore arm), PAIN (sore) and ARTHRALGIA (Being achy in joints) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported by reporter.  Concurrent medical conditions included Hypothyroidism since 23-Jan-2015. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) from 23-Jan-2015 to an unknown date for Hypothyroidism, VITAMIN C [ASCORBIC ACID], VITAMIN D NOS and ZINC for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 16-Mar-2021, the patient experienced DECREASED APPETITE (No appetite), COUGH (mild coughing), PAIN (sore), ARTHRALGIA (Being achy in joints), MYALGIA (being achy in joints and some muscles), PYREXIA (fever spike to 103.4F) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) on 16-Mar-2021 at a dose of 2 dosage form in total. On 05-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, DECREASED APPETITE (No appetite), COUGH (mild coughing), PAIN (sore), ARTHRALGIA (Being achy in joints), MYALGIA (being achy in joints and some muscles), PYREXIA (fever spike to 103.4F) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Blood immunoglobulin G: unknown (Positive) IgG positive. On 16-Mar-2021, Body temperature: 103.4 (High) 103.4 F. On 16-Mar-2021, COVID-19: unknown (Negative) COVID-19 negative. On 16-Mar-2021, Influenza virus test: unknown (Negative) Flu test negative. On 16-Mar-2021, Polymerase chain reaction: unknown (Negative) PCR negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26MAY2021, included patient demographic details, lab data  and medical history details.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood glucose increased, Chills, Fatigue, Illness
Clinical narrative: She was weak; Fever; Chills; She vomited; Rashes around injection site; Itchiness around injection site; Redness around injection site; So tired; She felt like vomiting; Elevated blood sugar at 365; Felt sick; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Elevated blood sugar at 365), ILLNESS (Felt sick), ASTHENIA (She was weak), VACCINATION SITE PRURITUS (Itchiness around injection site) and VOMITING (She felt like vomiting) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN and LISINOPRIL for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced BLOOD GLUCOSE INCREASED (Elevated blood sugar at 365), ILLNESS (Felt sick), VOMITING (She felt like vomiting) and FATIGUE (So tired). On 22-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness around injection site), VACCINATION SITE ERYTHEMA (Redness around injection site) and VACCINATION SITE RASH (Rashes around injection site). On 14-Mar-2021, the patient experienced ASTHENIA (She was weak), PYREXIA (Fever), CHILLS (Chills) and VOMITING (She vomited). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BLOOD GLUCOSE INCREASED (Elevated blood sugar at 365), ILLNESS (Felt sick), ASTHENIA (She was weak), VACCINATION SITE PRURITUS (Itchiness around injection site), VOMITING (She felt like vomiting), VACCINATION SITE ERYTHEMA (Redness around injection site), FATIGUE (So tired), PYREXIA (Fever), CHILLS (Chills), VOMITING (She vomited) and VACCINATION SITE RASH (Rashes around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vomiting
Clinical narrative: She was weak; Fever; Chills; She vomited; Rashes around injection site; Itchiness around injection site; Redness around injection site; So tired; She felt like vomiting; Elevated blood sugar at 365; Felt sick; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Elevated blood sugar at 365), ILLNESS (Felt sick), ASTHENIA (She was weak), VACCINATION SITE PRURITUS (Itchiness around injection site) and VOMITING (She felt like vomiting) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN and LISINOPRIL for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced BLOOD GLUCOSE INCREASED (Elevated blood sugar at 365), ILLNESS (Felt sick), VOMITING (She felt like vomiting) and FATIGUE (So tired). On 22-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness around injection site), VACCINATION SITE ERYTHEMA (Redness around injection site) and VACCINATION SITE RASH (Rashes around injection site). On 14-Mar-2021, the patient experienced ASTHENIA (She was weak), PYREXIA (Fever), CHILLS (Chills) and VOMITING (She vomited). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BLOOD GLUCOSE INCREASED (Elevated blood sugar at 365), ILLNESS (Felt sick), ASTHENIA (She was weak), VACCINATION SITE PRURITUS (Itchiness around injection site), VOMITING (She felt like vomiting), VACCINATION SITE ERYTHEMA (Redness around injection site), FATIGUE (So tired), PYREXIA (Fever), CHILLS (Chills), VOMITING (She vomited) and VACCINATION SITE RASH (Rashes around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Headache, Myalgia
Clinical narrative: headache; fatigue; Myalgia; muscle pain; Diarrhea; shortness of breath; rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DYSPNOEA (shortness of breath), VACCINATION SITE RASH (rash at the injection site), HEADACHE (headache) and FATIGUE (fatigue) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type 2 diabetes mellitus.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE RASH (rash at the injection site). On 15-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), DYSPNOEA (shortness of breath), HEADACHE (headache), FATIGUE (fatigue), MYALGIA (Myalgia) and MYALGIA (muscle pain). At the time of the report, DIARRHOEA (Diarrhea), DYSPNOEA (shortness of breath), VACCINATION SITE RASH (rash at the injection site), HEADACHE (headache), FATIGUE (fatigue), MYALGIA (Myalgia) and MYALGIA (muscle pain) outcome was unknown.            Treatment drugs were not provided concomitant drugs were not provided
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: headache; fatigue; Myalgia; muscle pain; Diarrhea; shortness of breath; rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DYSPNOEA (shortness of breath), VACCINATION SITE RASH (rash at the injection site), HEADACHE (headache) and FATIGUE (fatigue) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type 2 diabetes mellitus.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE RASH (rash at the injection site). On 15-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), DYSPNOEA (shortness of breath), HEADACHE (headache), FATIGUE (fatigue), MYALGIA (Myalgia) and MYALGIA (muscle pain). At the time of the report, DIARRHOEA (Diarrhea), DYSPNOEA (shortness of breath), VACCINATION SITE RASH (rash at the injection site), HEADACHE (headache), FATIGUE (fatigue), MYALGIA (Myalgia) and MYALGIA (muscle pain) outcome was unknown.            Treatment drugs were not provided concomitant drugs were not provided
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Lymph node pain, Nasal congestion, Throat tightness
Clinical narrative: feeling strange; tightness in back of his throat; stuffy nose; soreness in his lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling strange), THROAT TIGHTNESS (tightness in back of his throat), NASAL CONGESTION (stuffy nose) and LYMPH NODE PAIN (soreness in his lymph nodes) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0034211A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (feeling strange), THROAT TIGHTNESS (tightness in back of his throat), NASAL CONGESTION (stuffy nose) and LYMPH NODE PAIN (soreness in his lymph nodes). At the time of the report, FEELING ABNORMAL (feeling strange), THROAT TIGHTNESS (tightness in back of his throat), NASAL CONGESTION (stuffy nose) and LYMPH NODE PAIN (soreness in his lymph nodes) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Not specified
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Influenza like illness, Pain, Rhinorrhoea
Clinical narrative: flu-like symptoms; runny nose; achy; fatigue; chills; This spontaneous case was reported by a nurse and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), RHINORRHOEA (runny nose), PAIN (achy), FATIGUE (fatigue) and CHILLS (chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced RHINORRHOEA (runny nose), PAIN (achy), FATIGUE (fatigue) and CHILLS (chills). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), RHINORRHOEA (runny nose), PAIN (achy), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided. .   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received: Contain Non significant information
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Lip dry, Oral discomfort, Oral pain, Oropharyngeal discomfort, Sunburn
Clinical narrative: Little sores in her mouth including her palate; Mouth is "burning"; Throat "was not feeling right"; Felt that her face was sunburnt; Dry lips; This spontaneous case was reported by a consumer and describes the occurrence of SUNBURN (Felt that her face was sunburnt), LIP DRY (Dry lips), OROPHARYNGEAL DISCOMFORT (Throat "was not feeling right"), ORAL PAIN (Little sores in her mouth including her palate) and ORAL DISCOMFORT (Mouth is "burning") in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included Oral disorder (For which the patient was prescribed with a low dose antibiotic.) from October 2020 to January 2021.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced SUNBURN (Felt that her face was sunburnt) and LIP DRY (Dry lips). On 13-Mar-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (Throat "was not feeling right"). On 17-Mar-2021, the patient experienced ORAL PAIN (Little sores in her mouth including her palate) and ORAL DISCOMFORT (Mouth is "burning"). The patient was treated with AMOXICILLIN at a dose of 1 dosage form. On 12-Mar-2021, SUNBURN (Felt that her face was sunburnt) had resolved. At the time of the report, LIP DRY (Dry lips), OROPHARYNGEAL DISCOMFORT (Throat "was not feeling right"), ORAL PAIN (Little sores in her mouth including her palate) and ORAL DISCOMFORT (Mouth is "burning") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Retching
Clinical narrative: Dry heaves really bad; Dizziness; headache; i'm tired; This spontaneous case was reported by a consumer and describes the occurrence of RETCHING (Dry heaves really bad), DIZZINESS (Dizziness), HEADACHE (headache) and FATIGUE (i'm tired) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced RETCHING (Dry heaves really bad), DIZZINESS (Dizziness), HEADACHE (headache) and FATIGUE (i'm tired). At the time of the report, RETCHING (Dry heaves really bad), DIZZINESS (Dizziness), HEADACHE (headache) and FATIGUE (i'm tired) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitants were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: NNI-Reporter stated she does not have an email address or a faxnumber.